EUVIMEDEUVIMED entdecken
Crossref

Should “Transformed Alpha-fetoprotein” be considered a Potential Biomarker for Adverse Term Pregnancy Risk: An Opinion Letter

Gynecology and Women’s Health Care · 2020

DOI: 10.47485/2766-5879.1010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gynecology and Women’s Health Care, 2020. Die Arbeit nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human alpha-fetoprotein (HAFP), classified as a tumor-associated fetal protein, has been reported in the biomedical literature to display multiple molecular forms and complexes. Such forms have been demonstrated to include the following: 1) circulating serum full length HAFP; 2) non-secreted cell-bound cytoplasmic HAFP forms; 3) truncated mRNA expressed/translated forms largely found in cell culture supernatants; and 4) serum circulating inter-molecular complexed forms [1, 2]. Moreover, the native 70 kD circulating serum AFP form has long been employed in the clinic as a “gold standard” biomarker for hepatocellular carcinomas and germ cell tumors in addition to being a biomarker for fetal birth defects.

Zitieren

APA

(2020). Should “Transformed Alpha-fetoprotein” be considered a Potential Biomarker for Adverse Term Pregnancy Risk: An Opinion Letter. Gynecology and Women’s Health Care. https://doi.org/10.47485/2766-5879.1010

Vancouver

Should “Transformed Alpha-fetoprotein” be considered a Potential Biomarker for Adverse Term Pregnancy Risk: An Opinion Letter. Gynecology and Women’s Health Care. 2020. doi:10.47485/2766-5879.1010

BibTeX
@article{euvimed2020,
  title = {Should “Transformed Alpha-fetoprotein” be considered a Potential Biomarker for Adverse Term Pregnancy Risk: An Opinion Letter},
  journal = {Gynecology and Women’s Health Care},
  year = {2020},
  doi = {10.47485/2766-5879.1010}
}
Kostenlos starten →